Paper26817023
Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Damme M and 11 others. Ann Clin Transl Neurol, 2015. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice. Papers, record 26817023. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26817023
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4979627 | Mannosidosis: a clinical and histopathologic study. | J Pediatr | 1969 | https://conductscience.org/library/papers/4979627 | PubMed |
| 2 | 11179018 | A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. | Am J Hum Genet | 2001 | https://conductscience.org/library/papers/11179018 | PubMed |
| 3 | 12700165 | Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase. | Hum Mol Genet | 2003 | https://conductscience.org/library/papers/12700165 | PubMed |
| 4 | 23494656 | Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study. | J Inherit Metab Dis | 2013 | https://conductscience.org/library/papers/23494656 | PubMed |
| 5 | 197212 | Mannosidosis: pathology of the nervous system. | J Neuropathol Exp Neurol | 1977 | https://conductscience.org/library/papers/197212 | PubMed |
| 6 | 16211561 | Human and mouse microglia express connexin36, and functional gap junctions are formed between rodent microglia and neurons. | J Neurosci Res | 2005 | https://conductscience.org/library/papers/16211561 | PubMed |
| 7 | 22161967 | Identification of 83 novel alpha-mannosidosis-associated sequence variants: functional analysis of MAN2B1 missense mutations. | Hum Mutat | 2012 | https://conductscience.org/library/papers/22161967 | PubMed |
| 8 | 10657992 | Enzyme replacement therapy in a mouse model of aspartylglycosaminuria. | FASEB J | 2000 | https://conductscience.org/library/papers/10657992 | PubMed |
| 9 | 21946346 | Enzyme replacement therapy for lysosomal storage diseases. | Curr Opin Pediatr | 2011 | https://conductscience.org/library/papers/21946346 | PubMed |
| 10 | 22388935 | Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. | Hum Mol Genet | 2012 | https://conductscience.org/library/papers/22388935 | PubMed |
| 11 | 4967547 | Deficiency of beta-galactosidase and alpha-mannosidase--primary enzyme defects in gargoylism and a new generalized disease? | Acta Paediatr Scand | 1967 | https://conductscience.org/library/papers/4967547 | PubMed |
| 12 | 17942826 | Dose translation from animal to human studies revisited. | FASEB J | 2008 | https://conductscience.org/library/papers/17942826 | PubMed |
| 13 | 19174759 | Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. | Mol Ther | 2009 | https://conductscience.org/library/papers/19174759 | PubMed |
| 14 | 11439963 | Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11439963 | PubMed |
| 15 | 6996438 | The vascular system of the cerebral cortex. | Adv Anat Embryol Cell Biol | 1980 | https://conductscience.org/library/papers/6996438 | PubMed |
| 16 | 23027951 | Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23027951 | PubMed |
| 17 | 22704978 | Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. | Mol Genet Metab | 2012 | https://conductscience.org/library/papers/22704978 | PubMed |
| 18 | 9915946 | Spectrum of mutations in alpha-mannosidosis. | Am J Hum Genet | 1999 | https://conductscience.org/library/papers/9915946 | PubMed |
| 19 | 15979029 | Short-term, high dose enzyme replacement therapy in sialidosis mice. | Mol Genet Metab | 2005 | https://conductscience.org/library/papers/15979029 | PubMed |
| 20 | 3315809 | Trafficking of lysosomal enzymes. | FASEB J | 1987 | https://conductscience.org/library/papers/3315809 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35706761 | Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases. | GEN Biotechnol | 2022 | https://conductscience.org/library/papers/35706761 | PubMed |
| 32517081 | The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases. | Cells | 2020 | https://conductscience.org/library/papers/32517081 | PubMed |
| 31282275 | Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. | Autophagy | 2020 | https://conductscience.org/library/papers/31282275 | PubMed |
| 31040271 | The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells. | Nat Commun | 2019 | https://conductscience.org/library/papers/31040271 | PubMed |
| 29772816 | Alpha-Mannosidosis: Therapeutic Strategies. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29772816 | PubMed |
| 27491075 | A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. | Dis Model Mech | 2016 | https://conductscience.org/library/papers/27491075 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD68 | 968 | PubTator's text mining | https://conductscience.org/library/genes/968 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| GLB1 | 2720 | PubTator's text mining | https://conductscience.org/library/genes/2720 | NCBI Gene |
| GUSB | 2990 | PubTator's text mining | https://conductscience.org/library/genes/2990 | NCBI Gene |
| LAMP1 | 3916 | PubTator's text mining | https://conductscience.org/library/genes/3916 | NCBI Gene |
| LAMP2 | 3920 | PubTator's text mining | https://conductscience.org/library/genes/3920 | NCBI Gene |
| MAN2B1 | 4125 | PubTator's text mining | https://conductscience.org/library/genes/4125 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| OGA | 10724 | PubTator's text mining | https://conductscience.org/library/genes/10724 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26817023
GET https://conductscience.org/api/papers/v1/26817023/references?page=2